NutrigeneAI Biotech Limited is proud to have participated in the 51st International Exhibition of Inventions Geneva as part of the delegation from The Chinese University of Hong Kong (CUHK), contributing to the university’s outstanding achievements on the global stage.
During the exhibition, NutrigeneAI, as a CUHK startup, presented one of its key innovations developed under the leadership of Prof. Jack Wong and his research team. The showcased technology features the world’s first-in-class intramuscular injectable iPSC-derived cell therapeutic drug, designed to regenerate blood vessels and improve microcirculation.
